The page is the record's research on the issuer — no analyst, no rating, no view. # Camp4 Therapeutics Corp (NASDAQ: CAMP) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Camp4 Therapeutics Corp is listed on NASDAQ under the ticker CAMP, with ISIN US13463J1016. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted. ## The disclosure read The record holds 73 filings across 36 filing days in the window from 2025-11-08 to 2026-11-08. The filings comprise 27 directors' dealings, 20 regulatory filings, 8 corporate news, 6 prospectuses, 6 results, 2 AGM/EGM, 2 director changes, 1 ad hoc and 1 takeover. The median gap between filing days is 6 days. The latest filing is of type results, dated 2026-11-05, 3 days before the record date. The NASDAQ median filings are 52, the median cadence gap is 6.0 days and the median latency is 5.0 days across 4359 issuers. The 2834 Pharmaceutical Preparations sector median filings are 63.0, the median cadence gap is 6.0 days and the median latency is 4.0 days across 526 issuers. The issuer's filings count of 73 is above the NASDAQ median of 52 and above the sector median of 63.0. ## Auditor The auditor of record is Ernst & Young LLP, located in Boston, Massachusetts. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer is held in sealed years 2021, 2022, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001736730.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/CAMP (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1736730/000173673026000016/camp-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/CAMP (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/CAMP · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp